← Leaderboards
Lawrence F Chu
Stanford University
$2,706,537
Attributed
$2,706,537
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $596.3K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$2,410,763 · 3
AHRQ$295,774 · 1
By mechanism
R01$1,124,268 · 1
K23$653,235 · 1
K02$633,260 · 1
R13$295,774 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- David Raymond Drover$5,881,573
- Teri Ellen Klein$27,775,851
- Karl Alexander Deisseroth$77,564,196
- Veronica Yank$4,944,746
- Adam Frymoyer$731,997
Others in their field
Top investigators on “Analgesics”
- Richard T D'aquila · Massachusetts General Hospital$27,454,413
- Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai$25,078,909
- David J Julius · University Of California, San Francisco$24,283,903
- Sandra D. Comer · New York State Psychiatric Institute$21,433,459
- Lynn Kirkpatrick · Ensysce Biosciences, Inc.$20,649,999
- Maurizio Fava · Massachusetts General Hospital$19,316,294
Research focus
AnalgesicsPainBaseChronicOpioidResearch PersonnelPain ManagementPharmaceutical PreparationsClinical ResearchMorphineLinkCostDrug AbuseLaboratoriesCollaborationsDrug UsageMentorshipChronic PainAmerican12 Year OldHydrocodone/AcetaminophenCareerAcuteAddiction
Grant awards (16)
Understanding the Effects of Chronic Opioids Therapy in Humans$126,652
K02 · FY2017 · DA · contact PI
Understanding the Effects of Chronic Opioids Therapy in Humans$126,652
K02 · FY2016 · DA · contact PI
Understanding the Effects of Chronic Opioids Therapy in Humans$126,652
K02 · FY2015 · DA · contact PI
Understanding the Effects of Chronic Opioids Therapy in Humans$126,652
K02 · FY2014 · DA · contact PI
Stanford Medicine X-Health Care and Emerging Technologies$98,512
R13 · FY2014 · HS · contact PI
5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Phy$371,068
R01 · FY2013 · DA · contact PI
Understanding the Effects of Chronic Opioids Therapy in Humans$126,652
K02 · FY2013 · DA · contact PI
Stanford Medicine X-Health Care and Emerging Technologies$98,592
R13 · FY2013 · HS · contact PI
5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Phy$380,868
R01 · FY2012 · DA · contact PI
Stanford Medicine X-Health Care and Emerging Technologies$98,670
R13 · FY2012 · HS · contact PI
5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Phy$372,332
R01 · FY2011 · DA · contact PI
Opiate-Induced Tolerance & Hyperalgesia in Pain Patients$130,647
K23 · FY2008 · GM · contact PI
Opiate-Induced Tolerance & Hyperalgesia in Pain Patients$130,647
K23 · FY2007 · GM · contact PI
Opiate-Induced Tolerance & Hyperalgesia in Pain Patients$130,647
K23 · FY2006 · GM · contact PI
Opiate-Induced Tolerance &Hyperalgesia in Pain Patients$130,647
K23 · FY2005 · GM
Opiate-Induced Tolerance &Hyperalgesia in Pain Patients$130,647
K23 · FY2004 · GM